Natarajan Sethuraman - Net Worth and Insider Trading

Natarajan Sethuraman Net Worth

The estimated net worth of Natarajan Sethuraman is at least $3 Million dollars as of 2024-11-05. Natarajan Sethuraman is the President, Research & Develop. of Entrada Therapeutics Inc and owns about 183,216 shares of Entrada Therapeutics Inc (TRDA) stock worth over $3 Million. Details can be seen in Natarajan Sethuraman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Natarajan Sethuraman has not made any transactions after 2024-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Natarajan Sethuraman

To

Natarajan Sethuraman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Natarajan Sethuraman owns 1 companies in total, including Entrada Therapeutics Inc (TRDA) .

Click here to see the complete history of Natarajan Sethuraman’s form 4 insider trades.

Insider Ownership Summary of Natarajan Sethuraman

Ticker Comapny Transaction Date Type of Owner
TRDA Entrada Therapeutics Inc 2024-10-16 Chief Scientific Officer

Natarajan Sethuraman Latest Holdings Summary

Natarajan Sethuraman currently owns a total of 1 stock. Natarajan Sethuraman owns 183,216 shares of Entrada Therapeutics Inc (TRDA) as of October 16, 2024, with a value of $3 Million.

Latest Holdings of Natarajan Sethuraman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TRDA Entrada Therapeutics Inc 2024-10-16 183,216 17.86 3,271,322

Holding Weightings of Natarajan Sethuraman


Natarajan Sethuraman Form 4 Trading Tracker

According to the SEC Form 4 filings, Natarajan Sethuraman has made a total of 6 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 600 shares on October 16, 2024, which brought Natarajan Sethuraman around $10,800.

Insider Trading History of Natarajan Sethuraman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Natarajan Sethuraman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Natarajan Sethuraman Ownership Network

Ownership Network List of Natarajan Sethuraman

No Data

Ownership Network Relation of Natarajan Sethuraman

Insider Network Chart

Natarajan Sethuraman Owned Company Details

What does Entrada Therapeutics Inc do?

Who are the key executives at Entrada Therapeutics Inc?

Natarajan Sethuraman is the Chief Scientific Officer of Entrada Therapeutics Inc. Other key executives at Entrada Therapeutics Inc include Chief Operating Officer Nathan J Dowden , Chief Financial Officer Kory James Wentworth , and director & President and CEO Dipal Doshi .

Entrada Therapeutics Inc (TRDA) Insider Trades Summary

Over the past 18 months, Natarajan Sethuraman made 5 insider transaction in Entrada Therapeutics Inc (TRDA) with a net sale of 41,938. Other recent insider transactions involving Entrada Therapeutics Inc (TRDA) include a net sale of 12,900 shares made by Dipal Doshi , a net sale of 56,124 shares made by Nathan J Dowden , and a net sale of 49,989 shares made by Kory James Wentworth .

In summary, during the past 3 months, insiders sold 37,284 shares of Entrada Therapeutics Inc (TRDA) in total and bought 0 shares, with a net sale of 37,284 shares. During the past 18 months, 188,553 shares of Entrada Therapeutics Inc (TRDA) were sold and 45,368 shares were bought by its insiders, resulting in a net sale of 143,185 shares.

Entrada Therapeutics Inc (TRDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entrada Therapeutics Inc Insider Transactions

No Available Data

Natarajan Sethuraman Mailing Address

Above is the net worth, insider trading, and ownership report for Natarajan Sethuraman. You might contact Natarajan Sethuraman via mailing address: 6 Tide Street, Boston Ma 02210.